Dog Presence and Oxytocin on Trust Towards Therapists

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Depressive SymptomsHuman-Animal Interaction
Interventions
DRUG

Oxytocin nasal spray

Syntocinon nose spray is usually applied in the context of labour and breast feeding. In this study, however, it will be used to induce an oxytocin (OT) release. Participants will apply three sprays in each nostril which will result in a dose of 24 I.U of oxytocin per participant

OTHER

Animal-Assisted Intervention

The dogs involved in the study are trained and used to work with different people in animal-assisted interventions. The dog will be familiarized with the room and the material as well as the staff of the study. The dog will be specifically trained for this study. The dog will be involved for a maximum of 3 sessions per day (approx. 20 minutes in total) and 2 days per week.

DRUG

Placebo

The placebo nose spray contains a saltwater solution and will be applied like the Syntocinon nose spray containing oxytocin.

Trial Locations (1)

4055

RECRUITING

University of Basel, Basel

All Listed Sponsors
lead

Dr. Karin Hediger

OTHER